NervGen Pharma (9UA.MU) Q2 2026 Earnings

15MayConfirmed
Next
-0.06
0.27
0.6
0.94

Details

Expected EPS
-0.06361191069000001
Actual EPS
N/A
Surprise EPS
0.06
Surprise Percent
+100%

Description

NervGen Pharma (9UA.MU) will report earnings of for Q2 2026 on May 15, 2026.

0 Comments

Share your thoughts